How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 501–600 of 1,000
Angrisani, L., Cutolo, P. P., Formisano, G., Nosso, G., Santonicola, A., & Vitolo, G. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0877-3 · Cited by 13
“Complete remission was defined as a return to “normal” measures of glucose metabolism (A1C in the normal range (<6 %), fasting glucose [100 mg/dl]) after at least 1 year in the absence of active pharmacologic therapy [16].”
BackgroundMid‐Term Remission of Type 2 Diabetes Mellitus After Laparoscopic Roux En‐Y Gastric Bypass
Vasas, P., Al‐Khyatt, W., IDRIS, I. R., Leeder, P. C., Awan, A., Awad, S., & Ahmed, J. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3609-8 · Cited by 13
“The primary end-point of this study was remission of T2DM which was defined according to the American Diabetes Association (ADA) guidelines about the longterm glycaemic target [15, 16]: Complete remission (CR)—HbA1c\42 mmol/mol (6.”
MethodVitamin E induces regular structure and stability of human insulin, more intense than vitamin D3
Soleymani, H., Saboury, A. A., Moosavi‐Movahedi, A. A., Rahmani, F., Maleki, J., Yousefinejad, S., & Maghami, P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.09.047 · Cited by 14
Richter, B., Hemmingsen, B., Metzendorf, M., & Takwoingi, Y. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661 · Cited by 15
Laparoscopic sleeve gastrectomy for diabetics – 5-year outcomes
Lessing, Y., Pencovich, N., Lahat, G., Klausner, J. M., Abu‐Abeid, S., & Eldar, S. M. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.06.009 · Cited by 13
“We used the American Diabetes Association (ADA) definitions of diabetes “remission” - blood glucose levels under 100 mg/dl and HbA1c lower than 6 % while not under any medical treatment for T2DM (16,17) .”
MethodRamírez, E., Espinosa, O., Berrones, R., Sepúlveda, E. M., Guilbert, L., Solís, M. P., & Zerrweck, C. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3281-1 · Cited by 14
Madsen, L. R., Bek, T., & Richelsen, B. (2018) · Diabetic Medicine · doi:10.1111/dme.13876 · Cited by 14
Jurowich, C. F., Germer, C., Seyfried, F., & Thalheimer, A. (2012) · Der Chirurg · doi:10.1007/s00104-011-2239-9 · Cited by 17
Experience in biliopancreatic diversion with duodenal switch: Results at 2, 5 and 10 years
Sorribas, M., Casajoana, A., Sobrino, L., Admella, V., Osorio, J., & Pujol-Gebellí, J. (2022) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2022.03.015 · Cited by 13
Zeve, J. L. D. M., Tomaz, C. A. B., Nassif, P. A. N., de Lima, J. H. F., Sansana, L. R. Z., & Zeve, C. H. (2013) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202013000600011 · Cited by 13
Baseline Abdominal Lipid Partitioning Is Associated with the Metabolic Response to Bariatric Surgery
Keidar, A., Appelbaum, L., Schweiger, C., Hershkop, K. J., Matot, I., Constantini, N., Sosna, J., & Weiss, R. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1249-3 · Cited by 13
“Diabetes clinical remission was defined based on the ADA expert opinion for the assessment of glucose metabolism following bariatric procedures [17].”
MethodFoschi, D., Rizzi, A., Tubazio, I., Conti, L., Vago, T., Bevilacqua, M. T., Magni, A., & Puppo, M. D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.10.025 · Cited by 13
Long-term outcomes of bariatric surgery in patients with diabetes
Sudlow, A. C., le Roux, C. W., & Pournaras, D. J. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1754191 · Cited by 15
Bhattacharya, S., Kalra, S., Kapoor, N., Singla, R., Dutta, D., Aggarwal, S., Khandelwal, D., Surana, V., Dhingra, A., Kantroo, V., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1587 · Cited by 14
Queiroz, S., Gadelha, J. G., Husain, N., & Gutu, C. S. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07858-w · Cited by 13
“Buse et al. (2009) proposed clear benchmarks for evaluating diabetes remission, including sustained glycemic control without pharmacological intervention [31].”
Remission of Diabetes Following Bariatric Surgery: Plasma Proteomic Profiles
Insenser, M. R., Vilarrasa, N., Vendrell, J. J., & Escobar-Morreale, H. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173879 · Cited by 15
Alanine to glycine ratio is a novel predictive biomarker for type 2 diabetes mellitus
Lee, K. S., Lee, Y., & Lee, S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15395 · Cited by 12
“16 Intensive lifestyle modifications have been shown to induce T2D remission in approximately 10% of patients.”
BackgroundLee, W., Lee, M.-H., Yu, P., Wei, J.-H., Chong, K., Chen, S., Almulaifi, A. M., & Lee, Y.-C. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1520-7 · Cited by 15
Paik, K. Y., Kim, W., Song, K., Kwon, H., Kim, M. K., & Kim, E. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2341-1 · Cited by 13
Chen, Y., Inui, A., Chang, E.-S., Chen, S.-C., Lee, W., & Chen, C.-Y. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.11.002 · Cited by 12
“Influences of 1-mg intravenous glucagon on plasma cholecystokinin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and peptide YY profiles among patients with type 2 diabetes mellitus undergoing either Roux-en-Y gastric bypass or sleeve gastrectomy, as well as in the remitters and non-remitters…”
BackgroundInfluentialDu, X., Fu, X., Shi, L., Hu, J., Zhou, Z., & Cheng, Z. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2903-3 · Cited by 13
“5 kg/ m(2); (3) a diagnosis of T2DM based on American Diabetes Associat ion (ADA) cri ter ia [6] , with no ser ious hyperglycemia-associated complications; and (4) fasting C peptide (FCP) ≥ 50% of normal or a twofold increase in FCP during an oral glucose tolerance test (OGTT) at 2 h (2h-CP).”
MethodMudumbi, J. B. N., Ntwampe, S. K. O., Mekuto, L., Matsha, T. E., & Itoba-Tombo, E. F. (2018) · Environmental Monitoring and Assessment · doi:10.1007/s10661-018-6634-2 · Cited by 16
ALSHAWAF, E. M. M., Al‐Ozairi, E., Al-Asfar, F., Albeloushi, S., Kumari, S., Tuomilehto, J., & Arefanian, H. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.026 · Cited by 12
Type 2 diabetes: treating not managing
Morris, E. M., Jebb, S. A., & Aveyard, P. N. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30071-3 · Cited by 12
Jørgensen, N. B., Bojsen-Møller, K. N., Dirksen, C., Martinussen, C., Svane, M. S., Kristiansen, V. B., Holst, J. J., & Madsbad, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-51516-y · Cited by 12
Miras, A. D., Kamocka, A., Tan, T., Pérez‐Pevida, B., Chahal, H., Moorthy, K., Purkayastha, S., Patel, A. G., Umpleby, A. M., Frost, G. S., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08030 · Cited by 14
“30 Long limb 24 66 (15) 56 (12) –1 (–3 to 1)”
BackgroundSelf-citationKraljević, M., Schneider, R., Wölnerhanssen, B. K., Bueter, M., Delko, T., & Peterli, R. (2021) · Trials · doi:10.1186/s13063-021-05313-6 · Cited by 12
Billmann, F. G., Shishtawi, S. E., Bruckner, T., ElSheikh, M., Müller-Stich, B. P., & Billeter, A. T. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-71 · Cited by 12
“Remission of T2DM was achieved when all of the following criteria were fulfilled: fasting glucose 100 mg/dL, HbA1c <6.0% and no use of antidiabetic medication, according to the 2009 consensus conference (25).”
InfluentialManning, S., Pucci, A. B. F., Batterham, R. L., & Finer, N. (2013) · Diabetes Care · doi:10.2337/dc13-0810 · Cited by 12
Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery
Andrew, C. A., Umashanker, D., Aronne, L. J., & Shukla, A. P. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0302-2 · Cited by 13
Oncometabolic surgery: Emergence and legitimacy for investigation
Kim, W. J., Kwon, Y., Lee, C. M., Lim, S. H., Li, Y., Wang, J., Hu, W., Zheng, J., Zhao, G., Zhu, C., et al. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.02.12 · Cited by 13
“The ABCD and DiaRem scoring systems also respectively incorporate duration of T2DM and treatment with insulin or drugs other than metformin as negative predictive factors of the success of metabolic surgery (43,45).”
BackgroundMethodMechanisms and the strategy for remission of type 2 diabetes mellitus
Chang, T. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13948 · Cited by 12
Astbury, N. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15855 · Cited by 12
“20 In 2021, a global expert panel revised the original ADA consensus statement on remission of type 2 diabetes to recommend a revised definition of diabetes remission to be a sustained metabolic improvement (HbA1c 48 mmol/mol 6.5% or fasting glucose 7.0 mmol/L) sustained for at least 3 months in…”
InfluentialPak, J., Kwon, Y., Menzo, E. L., Park, S. S., Szomstein, S., & Rosenthal, R. J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.008 · Cited by 11
Wentworth, J. M., Cheng, C., Laurie, C., Skinner, S. A., Burton, P. R., Brown, W. A., & O’Brien, P. E. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2944-7 · Cited by 11
Weight loss before bariatric surgery and its impact on poor versus excellent outcomes at 2 years
Rodríguez, F., Herrera-González, A., Sepúlveda, E. M., Guilbert, L., Hernández, L. A., Peñuñuri, L. F., Rodríguez, F. M., & Zerrweck, C. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02399-z · Cited by 11
Yin, H., Chen, W., Dong, L., Zhou, S., Qu, Q., Zhang, N., & He, X. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00880-3 · Cited by 12
Remission in Ketosis-Prone Diabetes
Kikani, N. J., & Balasubramanyam, A. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.06.005 · Cited by 11
Liu, Y., Sheng, C., Feng, W., Sun, F., Zhang, J., Chen, Y., Su, L., Liu, J., Du, L., Jia, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989202 · Cited by 14
Downgrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter
Runkel, M., Müller, S., Brydniak, R., & Runkel, N. S. F. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1419-3 · Cited by 11
Kaska, Ł., Proczko, M., Kobiela, J., Stefaniak, T., & Śledziński, Z. (2014) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2014.44427 · Cited by 11
“It means that the strict diabetes remission criteria recommended by ADA for HbA1c ≤ 6% and FPG ≤ 100 mg% were achieved without anti-diabetic medications [14, 15].”
BackgroundDesiderio, J., Trastulli, S., Scalercio, V., Cirocchi, R., Carloni, G., Moriconi, E., Boselli, C., Noya, G., & Amilcare, P. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0308 · Cited by 11
Effect of weight loss on abnormal 24-hour blood pressure patterns in severely obese patients
Careaga, M., Esmatjes, E., Núñez, I., Molero, J., Vidal, J., & Flores, L. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.12.022 · Cited by 14
“5%, respectively) in the absence of antidiabetic medication [11].”
BackgroundWood, G. C., Gerhard, G. S., Benotti, P. N., Petrick, A. T., Gabrielsen, J. D., Strodel, W. E., Ibele, A. R., Rolston, D. D. K., Still, C. D., & Argyropoulos, G. A. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000588 · Cited by 11
Fonseca, D. C., Sala, P., Singer, J., Singer, P., Torrinhas, R. S., & Waitzberg, D. L. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3098-3 · Cited by 11
A Computational Method for Learning Disease Trajectories From Partially Observable EHR Data
Oh, W., Steinbach, M. S., Castro, M. R., PETERSON, K. A., Kumar, V., Caraballo, P. J., & Simon, G. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3089441 · Cited by 11
Defining type 2 diabetes remission: KISS goodbye to confusion?
Taheri, S. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00290-4 · Cited by 11
FATIMA, K., FAROOQUI, S. K., Izma, A. J. A. Z., ALI, S. T., HASHMI, N., NADEEM, S., GHAZI, S. A., KALEEM, S. H., BOZDAR, F. S., & NOORANI, M. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03117-5 · Cited by 12
Zhao, J., Jiang, Y., Qian, J., Qian, Z., Yang, H., Shi, W., Gong, Y., Jiao, Y., & Tang, L. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.07.014 · Cited by 12
Broek, M., de Heide, L. J. M., Veeger, N. J. G. M., van der Wal-Oost, A. M., & Beek, V. A. (2016) · Obesity Facts · doi:10.1159/000446744 · Cited by 12
Cho, E.-Y., Kemmet, O., & Frenken, M. (2011) · Obesity Facts · doi:10.1159/000327037 · Cited by 11
Influence of Patient Choice on Outcome of Bariatric Surgery
Vasas, P., Nehemiah, S., Hussain, A., Finney, J., Kirk, K., Yeluri, S., & Balchandra, S. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2871-7 · Cited by 11
“For diabetes remission, we employed the American Diabetes Association’s (ADA) guideline [5].”
MethodAbouzeid, T., Shoka, A. A. A., & Atia, K. S. A. E. (2018) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2018.04.002 · Cited by 13
Huang, Y., Lin, Y., Lee, W., Hur, K. Y., Kasama, K., Cheng, A. K. S., Lee, M., Wong, S. K., Soong, T., Lee, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14279 · Cited by 11
Artero, A., Martinez‐Ibañez, J., Civera, M., Martínez-Valls, J. F., Ortega, J., Real, J. T., & Ascaso, J. F. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.03.013 · Cited by 11
Zhao, X. Y., Duan, W., Sun, C., Li, Z., Liu, Y., Xiao, X., Wang, G., Gang, X., & Wang, G. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5612049 · Cited by 11
The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol
Twells, L., Gregory, D. M., Midodzi, W. K., Dillon, C. M., Kovács, C. S., MacDonald, D., Lester, K. K., Pace, D., Smith, C., Boone, D. C., et al. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1869-5 · Cited by 12
“Additional criteria will used to assess improvement and resolution of prediabetes and diabetes [67].”
BackgroundMethodBhandari, M., Nautiyal, H. K., Mathur, W., & Kosta, S. (2019) · Clinical Obesity · doi:10.1111/cob.12308 · Cited by 10
Predictors of diabetes relapse after metabolic surgery in Asia
Yang, P., Su, Y., Shen, S., Lee, P., Lin, M., Lee, W., & Wang, W. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.11.018 · Cited by 10
Lin, C., Yeong, T. J. J., Lim, W. H., Ng, C. H., Yau, C. E., Chin, Y. H., Muthiah, M. D., Loh, P. H., Foo, R., Mok, S. F., et al. (2022) · Obesity · doi:10.1002/oby.23453 · Cited by 12
Saarinen, I., Grönroos, S., Hurme, S. A. M., Peterli, R., Helmiö, M., Bueter, M., Strandberg, M., Wölnerhanssen, B. K., & Salminen, P. T. P. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.10.036 · Cited by 10
Zenti, M. G., Rubbo, I., Ceradini, G., Rinaldi, E., Nadalini, L., Battistoni, M., Genna, M., Bonora, E., & Zoppini, G. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0738-8 · Cited by 13
“Diabetes remission was defined as glycated hemoglobin (HbA1c) \42 mmol/mol Hb (6 %) and fasting blood glucose (FBG) \100 mg/dl off diabetic medications, according to ADA 2009 criteria [15].”
MethodEspinosa, O., Pineda, O., Maydón, H., Sepúlveda, E. M., Guilbert, L., Amado, M., & Zerrweck, C. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5815-3 · Cited by 11
A low-carbohydrate survey: Evidence for sustainable metabolic syndrome reversal
Cucuzzella, M. T., Tondt, J., Dockter, N. E., Saslow, L. R., & Wood, T. R. (2017) · Journal of Metabolic Health · doi:10.4102/jir.v2i1.30 · Cited by 12
Park, D. G., Chung, Y., Kim, S. H., & Kim, Y. J. (2020) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2020.9.1.13 · Cited by 11
Cirurgia metabólica: mudanças na anatomia gastrointestinal e a remissão do diabetes mellitus tipo 2
COHEN, R. V., Torres, M. C., & Schiavon, C. A. (2010) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202010000100010 · Cited by 10
Ceriani, V., Cetta, F., Lodi, T., Pinna, F., & Pontiroli, A. E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2479-3 · Cited by 10
Tu, Y., Wang, L., Wei, L., Xu, Y., Han, X., Han, J., Yu, H., Zheng, C., Bao, Y., & Jia, W. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04069-y · Cited by 11
Wang, Z., Gao, L., Guo, X., Feng, C., Deng, K., Lian, W., Feng, M., Bao, X., & Xing, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00736 · Cited by 10
Mittal, T., Ahuja, A., Dey, A., Malik, V. K., Sheikh, M. T. M., Bansal, N. K., & Kanuri, H. (2021) · Surgical Endoscopy · doi:10.1007/s00464-021-08587-8 · Cited by 10
Nautiyal, H. K., Guan, W., Lin, S., & Liang, H. (2020) · Clinical Obesity · doi:10.1111/cob.12350 · Cited by 10
Yu, Z., Li, W., Sun, X., Tang, H., Li, P., Ji, G., Zhu, L., & Zhu, S. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05544-1 · Cited by 10
Vilafranca Cartagena, M., Arreciado Marañón, A., Artigues-Barbera, E., & Tort-Nasarre, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114041 · Cited by 9
Corrao, S., Falcone, F., Mirarchi, L., Amodeo, S., & Calvo, L. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01761-4 · Cited by 13
“%) for at least 3 months, without the need for glucose-lowering medications [11].”
Bariatric metabolic surgery: An effective treatment of type 2 diabetes
Bhandari, V., Kosta, S., Bhandari, M., Bhandari, M., Mathur, W., & Fobi, M. A. L. (2021) · Journal of Minimal Access Surgery · doi:10.4103/jmas.jmas_325_20 · Cited by 11
“[6] After addressing the challenges concerned in the demarcation of a cure or remission of T2DM, on the basis of three criteria: glycaemia below diabetic range, absence of treatment, and sustainability over time a definition is provided by this panel.”
Quantifying Remission Probability in Type 2 Diabetes Mellitus
Kalra, S., Bantwal, G., Kapoor, N., Sahay, R. K., Bhattacharya, S., Anne, B., Gopal, R. A., Kota, S. K., Kumar, A., Joshi, A. S., et al. (2021) · Clinics and Practice · doi:10.3390/clinpract11040100 · Cited by 11
“Complete remission implied the maintenance of normal glycemic parameters for a minimum duration of one year [12,16].”
BackgroundMethodSoroceanu, R. P., Timofte, D. V., Maxim, M., Platon, R., Vlăsceanu, V. I., Ciuntu, B. M., Pînzariu, A. C., Clim, A., Soroceanu, A., Silistraru, I., et al. (2023) · Nutrients · doi:10.3390/nu15051134 · Cited by 11
Pang, W. S., Loo, G. H., Tan, G. J., Mardan, M., Rajan, R., & Kosai, N. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-51384-1 · Cited by 9
Lahooti, A., Rizvi, A., Canakis, A., Akagbosu, C., Johnson, K. E., Hassan, K., Lahooti, I., Abu-Hammour, M., Dawod, E., Dawod, Q. M., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07408-w · Cited by 10
“In contrast, “complete” remission was defined as having an HbA1c level below 5.7%, fasting glucose levels below 100 mg/dL [5.6 mmol/L], and no dependence on antidiabetic medications for a minimum duration of 12 months [23].”
InfluentialTechniques, assessment, and effectiveness of bariatric surgery in combating obesity
le Roux, C. W. (2010) · Open Access Surgery · doi:10.2147/oas.s7195 · Cited by 11
“the criteria used to define remission may now be outdated, and stricter criteria will result in much lower rates of remission.(52) However, the meta-analysis showed that 78.”
Cho, S. W., Kim, S., Kim, Y., Yoon, S., & Jo, M. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e74 · Cited by 9
Wei, Y., Wong, S. K., Wu, T., Law, B. T. T., Ng, E. K., Lam, C. L. K., & Wong, C. K. H. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13179 · Cited by 10
Folie, S., Radlinger, B., Goebel, G., Salzmann, K., Staudacher, G., Ress, C., Tilg, H., & Kaser, S. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108837 · Cited by 9
Karera, M. G. D., Wentzel, A., Ishimwe, M. C. S., Gatete, J. D. D., Jagannathan, R., Horlyck-Romanovsky, M., & Sumner, A. E. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s403054 · Cited by 9
Bruno, G., Gruden, G., Barutta, F., Perin, P. C., Morino, M., & Toppino, M. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.017 · Cited by 10
Chen, M. Z., Hudson, C. A., Vincent, E. E., de Berker, D. A. R., May, M., Hers, I., Dayan, C. M., Andrews, R. C., & Tavaré, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120084 · Cited by 9
“Despite this considerable weight-loss in patients with T2DM, studies have shown that although diabetes control is improved in the majority, a ‘cure’ (confirmed against 2009 ADA agreed criteria for remission [25]) is only seen in 40–50% of patients undergoing bariatric surgery [26, 27] and, of these, 10% see a recurren…”
BackgroundBehbehani, F., Ammori, B. J., New, J. P., Summers, L. K. M., Soran, H., & Syed, A. A. (2014) · QJM · doi:10.1093/qjmed/hcu060 · Cited by 11
“Remission of diabetes was defined as complete (HbA1c < 42 mmol/mol) or partial (HbA1c 42–48 mmol/mol) in the absence of active pharmacologic therapy.(13) Comparisons of means were performed by Student’s t-test, and contingency tables of categorical variables were analysed by Fisher’s exact test.”
MethodWhat is the evidence for metabolic surgery for type 2 diabetes? A critical perspective
Amouyal, C., & Andréelli, F. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.06.005 · Cited by 10
Lee, S. H., Cho, M. H., Kim, Y. H., & Chung, S. (2017) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2017.26.1.71 · Cited by 9
Guilbert, L., Joo, P., Ortiz, C., Sepúlveda, E. M., Alabi, F., León, A. D. B. D., Piña, T., & Zerrweck, C. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.023 · Cited by 9
The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes
Marchetti, G., Ardengh, A. O., Colombo‐Souza, P., Kassab, P., de Freitas, W. R., & Ilias, E. J. (2020) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20202655 · Cited by 9
External validation of predictive scores for diabetes remission after metabolic surgery
Karpińska, I. A., Choma, J., Wysocki, M., Dudek, A., Małczak, P., Szopa, M., Pędziwiatr, M., & Major, P. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02260-3 · Cited by 10
Park, M., Kim, D., Park, B. J., Kim, S., Park, S. S., & Rosenthal, R. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.05.012 · Cited by 9
Herrera, M. F., García‐García, E., Arellano-Ramos, J. F., Madero, M. A., Aldrete-Velasco, J. A., & Corvalá, J. A. L. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3357-y · Cited by 11
Type 2 Diabetes Mellitus non-surgical remission: A possible mission
Allam, M. M., & El‐Zawawy, H. T. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100206 · Cited by 9
“Each definition of remission requires the absence of pharmacologic treatment during the defined observation period [6].”
BackgroundChang, A., Pina, L., Harris, D., Wood, G. C., Obradovic, V. N., & Parker, D. M. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.11.004 · Cited by 9
GLP-1 and GIP Changes after Sleeve Gastrectomy and Weight Regain in Adolescents. Do we need a Boost?
Shehata, M. A., Elhaddad, A., Mansour, M., Shehata, S. M. K., & Attar, A. E. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08168-x · Cited by 8
“Remission of type 2 diabetes mellitus (T2DM) was defined as HbA1c 6.5% without the use of anti-diabetic medications, in accordance with the American Diabetes Association (ADA) criteria [14].”
InfluentialHuang, Q.-S., Huang, L., Zhao, R., Yang, L., & Zhou, Z. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.09.153 · Cited by 9
Park, J. M., Chiu, C., Chen, S.-C., Lee, W., & Chen, C.-Y. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102032 · Cited by 8
Ke, Z., Fan, L., Zhou, X., Sun, F., Zhu, Z., & Tong, W. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.013 · Cited by 8
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.